カテゴリー： Market Monitor Global, 世界, 医療/バイオ

月経前症候群治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Premenstrual Syndrome Medicine Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8591 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：78 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Premenstrual Syndrome Medicine Market 調査レポートは次の情報を含め、グローバルにおけるの月経前症候群治療薬市場規模と予測を収録しています。・世界の月経前症候群治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の月経前症候群治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の月経前症候群治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「PH-80PMD」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

月経前症候群治療薬のグローバル主要企業は、Asarina Pharma AB、 Pherin Pharmaceuticals Incなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、月経前症候群治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の月経前症候群治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の月経前症候群治療薬市場：タイプ別市場シェア、2022年
・PH-80PMD、エストロゲン、プロゲステロン、その他

世界の月経前症候群治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の月経前症候群治療薬市場：用途別市場シェア、2022年
・在宅医療、病院、診療所

世界の月経前症候群治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の月経前症候群治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における月経前症候群治療薬のグローバル売上、2018年-2023年
・主要企業における月経前症候群治療薬のグローバル売上シェア、2022年
・主要企業における月経前症候群治療薬のグローバル販売量、2018年-2023年
・主要企業における月経前症候群治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Asarina Pharma AB、 Pherin Pharmaceuticals Inc

*************************************************************

・調査・分析レポートの概要
月経前症候群治療薬市場の定義
市場セグメント
世界の月経前症候群治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の月経前症候群治療薬市場規模
世界の月経前症候群治療薬市場規模：2022年 VS 2029年
世界の月経前症候群治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの月経前症候群治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の月経前症候群治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：PH-80PMD、エストロゲン、プロゲステロン、その他
月経前症候群治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：在宅医療、病院、診療所
月経前症候群治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別月経前症候群治療薬市場規模 2022年と2029年
地域別月経前症候群治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Asarina Pharma AB、 Pherin Pharmaceuticals Inc
...

This report aims to provide a comprehensive presentation of the global market for Premenstrual Syndrome Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premenstrual Syndrome Medicine. This report contains market size and forecasts of Premenstrual Syndrome Medicine in global, including the following market information:
Global Premenstrual Syndrome Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Premenstrual Syndrome Medicine Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Premenstrual Syndrome Medicine companies in 2022 (%)
The global Premenstrual Syndrome Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
PH-80PMD Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Premenstrual Syndrome Medicine include Asarina Pharma AB and Pherin Pharmaceuticals Inc etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Premenstrual Syndrome Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Premenstrual Syndrome Medicine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Premenstrual Syndrome Medicine Market Segment Percentages, by Type, 2022 (%)
PH-80PMD
Estrogen
Progesterone
Others
Global Premenstrual Syndrome Medicine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Premenstrual Syndrome Medicine Market Segment Percentages, by Application, 2022 (%)
Home Care
Hospital
Clinic
Global Premenstrual Syndrome Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Premenstrual Syndrome Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Premenstrual Syndrome Medicine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Premenstrual Syndrome Medicine revenues share in global market, 2022 (%)
Key companies Premenstrual Syndrome Medicine sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Premenstrual Syndrome Medicine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Asarina Pharma AB
Pherin Pharmaceuticals Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Premenstrual Syndrome Medicine, market overview.
Chapter 2: Global Premenstrual Syndrome Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Premenstrual Syndrome Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Premenstrual Syndrome Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Premenstrual Syndrome Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Premenstrual Syndrome Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Premenstrual Syndrome Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Premenstrual Syndrome Medicine Overall Market Size
2.1 Global Premenstrual Syndrome Medicine Market Size: 2022 VS 2029
2.2 Global Premenstrual Syndrome Medicine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Premenstrual Syndrome Medicine Sales: 2018-2029
3 Company Landscape
3.1 Top Premenstrual Syndrome Medicine Players in Global Market
3.2 Top Global Premenstrual Syndrome Medicine Companies Ranked by Revenue
3.3 Global Premenstrual Syndrome Medicine Revenue by Companies
3.4 Global Premenstrual Syndrome Medicine Sales by Companies
3.5 Global Premenstrual Syndrome Medicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Premenstrual Syndrome Medicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Premenstrual Syndrome Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Premenstrual Syndrome Medicine Players in Global Market
3.8.1 List of Global Tier 1 Premenstrual Syndrome Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Premenstrual Syndrome Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Premenstrual Syndrome Medicine Market Size Markets, 2022 & 2029
4.1.2 PH-80PMD
4.1.3 Estrogen
4.1.4 Progesterone
4.1.5 Others
4.2 By Type – Global Premenstrual Syndrome Medicine Revenue & Forecasts
4.2.1 By Type – Global Premenstrual Syndrome Medicine Revenue, 2018-2023
4.2.2 By Type – Global Premenstrual Syndrome Medicine Revenue, 2024-2029
4.2.3 By Type – Global Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
4.3 By Type – Global Premenstrual Syndrome Medicine Sales & Forecasts
4.3.1 By Type – Global Premenstrual Syndrome Medicine Sales, 2018-2023
4.3.2 By Type – Global Premenstrual Syndrome Medicine Sales, 2024-2029
4.3.3 By Type – Global Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
4.4 By Type – Global Premenstrual Syndrome Medicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Premenstrual Syndrome Medicine Market Size, 2022 & 2029
5.1.2 Home Care
5.1.3 Hospital
5.1.4 Clinic
5.2 By Application – Global Premenstrual Syndrome Medicine Revenue & Forecasts
5.2.1 By Application – Global Premenstrual Syndrome Medicine Revenue, 2018-2023
5.2.2 By Application – Global Premenstrual Syndrome Medicine Revenue, 2024-2029
5.2.3 By Application – Global Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
5.3 By Application – Global Premenstrual Syndrome Medicine Sales & Forecasts
5.3.1 By Application – Global Premenstrual Syndrome Medicine Sales, 2018-2023
5.3.2 By Application – Global Premenstrual Syndrome Medicine Sales, 2024-2029
5.3.3 By Application – Global Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
5.4 By Application – Global Premenstrual Syndrome Medicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Premenstrual Syndrome Medicine Market Size, 2022 & 2029
6.2 By Region – Global Premenstrual Syndrome Medicine Revenue & Forecasts
6.2.1 By Region – Global Premenstrual Syndrome Medicine Revenue, 2018-2023
6.2.2 By Region – Global Premenstrual Syndrome Medicine Revenue, 2024-2029
6.2.3 By Region – Global Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
6.3 By Region – Global Premenstrual Syndrome Medicine Sales & Forecasts
6.3.1 By Region – Global Premenstrual Syndrome Medicine Sales, 2018-2023
6.3.2 By Region – Global Premenstrual Syndrome Medicine Sales, 2024-2029
6.3.3 By Region – Global Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Premenstrual Syndrome Medicine Revenue, 2018-2029
6.4.2 By Country – North America Premenstrual Syndrome Medicine Sales, 2018-2029
6.4.3 US Premenstrual Syndrome Medicine Market Size, 2018-2029
6.4.4 Canada Premenstrual Syndrome Medicine Market Size, 2018-2029
6.4.5 Mexico Premenstrual Syndrome Medicine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Premenstrual Syndrome Medicine Revenue, 2018-2029
6.5.2 By Country – Europe Premenstrual Syndrome Medicine Sales, 2018-2029
6.5.3 Germany Premenstrual Syndrome Medicine Market Size, 2018-2029
6.5.4 France Premenstrual Syndrome Medicine Market Size, 2018-2029
6.5.5 U.K. Premenstrual Syndrome Medicine Market Size, 2018-2029
6.5.6 Italy Premenstrual Syndrome Medicine Market Size, 2018-2029
6.5.7 Russia Premenstrual Syndrome Medicine Market Size, 2018-2029
6.5.8 Nordic Countries Premenstrual Syndrome Medicine Market Size, 2018-2029
6.5.9 Benelux Premenstrual Syndrome Medicine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Premenstrual Syndrome Medicine Revenue, 2018-2029
6.6.2 By Region – Asia Premenstrual Syndrome Medicine Sales, 2018-2029
6.6.3 China Premenstrual Syndrome Medicine Market Size, 2018-2029
6.6.4 Japan Premenstrual Syndrome Medicine Market Size, 2018-2029
6.6.5 South Korea Premenstrual Syndrome Medicine Market Size, 2018-2029
6.6.6 Southeast Asia Premenstrual Syndrome Medicine Market Size, 2018-2029
6.6.7 India Premenstrual Syndrome Medicine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Premenstrual Syndrome Medicine Revenue, 2018-2029
6.7.2 By Country – South America Premenstrual Syndrome Medicine Sales, 2018-2029
6.7.3 Brazil Premenstrual Syndrome Medicine Market Size, 2018-2029
6.7.4 Argentina Premenstrual Syndrome Medicine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Premenstrual Syndrome Medicine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Premenstrual Syndrome Medicine Sales, 2018-2029
6.8.3 Turkey Premenstrual Syndrome Medicine Market Size, 2018-2029
6.8.4 Israel Premenstrual Syndrome Medicine Market Size, 2018-2029
6.8.5 Saudi Arabia Premenstrual Syndrome Medicine Market Size, 2018-2029
6.8.6 UAE Premenstrual Syndrome Medicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Asarina Pharma AB
7.1.1 Asarina Pharma AB Company Summary
7.1.2 Asarina Pharma AB Business Overview
7.1.3 Asarina Pharma AB Premenstrual Syndrome Medicine Major Product Offerings
7.1.4 Asarina Pharma AB Premenstrual Syndrome Medicine Sales and Revenue in Global (2018-2023)
7.1.5 Asarina Pharma AB Key News & Latest Developments
7.2 Pherin Pharmaceuticals Inc
7.2.1 Pherin Pharmaceuticals Inc Company Summary
7.2.2 Pherin Pharmaceuticals Inc Business Overview
7.2.3 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Major Product Offerings
7.2.4 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales and Revenue in Global (2018-2023)
7.2.5 Pherin Pharmaceuticals Inc Key News & Latest Developments
8 Global Premenstrual Syndrome Medicine Production Capacity, Analysis
8.1 Global Premenstrual Syndrome Medicine Production Capacity, 2018-2029
8.2 Premenstrual Syndrome Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Premenstrual Syndrome Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Premenstrual Syndrome Medicine Supply Chain Analysis
10.1 Premenstrual Syndrome Medicine Industry Value Chain
10.2 Premenstrual Syndrome Medicine Upstream Market
10.3 Premenstrual Syndrome Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Premenstrual Syndrome Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Premenstrual Syndrome Medicine in Global Market
Table 2. Top Premenstrual Syndrome Medicine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Premenstrual Syndrome Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Premenstrual Syndrome Medicine Revenue Share by Companies, 2018-2023
Table 5. Global Premenstrual Syndrome Medicine Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Premenstrual Syndrome Medicine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Premenstrual Syndrome Medicine Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Premenstrual Syndrome Medicine Product Type
Table 9. List of Global Tier 1 Premenstrual Syndrome Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Premenstrual Syndrome Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Premenstrual Syndrome Medicine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Premenstrual Syndrome Medicine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Premenstrual Syndrome Medicine Sales (K Pcs), 2018-2023
Table 15. By Type - Global Premenstrual Syndrome Medicine Sales (K Pcs), 2024-2029
Table 16. By Application – Global Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Premenstrual Syndrome Medicine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Premenstrual Syndrome Medicine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Premenstrual Syndrome Medicine Sales (K Pcs), 2018-2023
Table 20. By Application - Global Premenstrual Syndrome Medicine Sales (K Pcs), 2024-2029
Table 21. By Region – Global Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Premenstrual Syndrome Medicine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Premenstrual Syndrome Medicine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Premenstrual Syndrome Medicine Sales (K Pcs), 2018-2023
Table 25. By Region - Global Premenstrual Syndrome Medicine Sales (K Pcs), 2024-2029
Table 26. By Country - North America Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Premenstrual Syndrome Medicine Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Premenstrual Syndrome Medicine Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Premenstrual Syndrome Medicine Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Premenstrual Syndrome Medicine Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Premenstrual Syndrome Medicine Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Premenstrual Syndrome Medicine Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Premenstrual Syndrome Medicine Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Premenstrual Syndrome Medicine Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Premenstrual Syndrome Medicine Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Premenstrual Syndrome Medicine Sales, (K Pcs), 2024-2029
Table 46. Asarina Pharma AB Company Summary
Table 47. Asarina Pharma AB Premenstrual Syndrome Medicine Product Offerings
Table 48. Asarina Pharma AB Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Asarina Pharma AB Key News & Latest Developments
Table 50. Pherin Pharmaceuticals Inc Company Summary
Table 51. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Product Offerings
Table 52. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Pherin Pharmaceuticals Inc Key News & Latest Developments
Table 54. Premenstrual Syndrome Medicine Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 55. Global Premenstrual Syndrome Medicine Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Premenstrual Syndrome Medicine Production by Region, 2018-2023 (K Pcs)
Table 57. Global Premenstrual Syndrome Medicine Production by Region, 2024-2029 (K Pcs)
Table 58. Premenstrual Syndrome Medicine Market Opportunities & Trends in Global Market
Table 59. Premenstrual Syndrome Medicine Market Drivers in Global Market
Table 60. Premenstrual Syndrome Medicine Market Restraints in Global Market
Table 61. Premenstrual Syndrome Medicine Raw Materials
Table 62. Premenstrual Syndrome Medicine Raw Materials Suppliers in Global Market
Table 63. Typical Premenstrual Syndrome Medicine Downstream
Table 64. Premenstrual Syndrome Medicine Downstream Clients in Global Market
Table 65. Premenstrual Syndrome Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Premenstrual Syndrome Medicine Segment by Type in 2022
Figure 2. Premenstrual Syndrome Medicine Segment by Application in 2022
Figure 3. Global Premenstrual Syndrome Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Premenstrual Syndrome Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Premenstrual Syndrome Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. Premenstrual Syndrome Medicine Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Premenstrual Syndrome Medicine Revenue in 2022
Figure 9. By Type - Global Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
Figure 12. By Type - Global Premenstrual Syndrome Medicine Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
Figure 16. By Application - Global Premenstrual Syndrome Medicine Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Premenstrual Syndrome Medicine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
Figure 21. By Country - North America Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
Figure 23. US Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
Figure 28. Germany Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. France Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
Figure 37. China Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. India Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
Figure 44. Brazil Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Premenstrual Syndrome Medicine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Premenstrual Syndrome Medicine Sales Market Share, 2018-2029
Figure 48. Turkey Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Premenstrual Syndrome Medicine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Premenstrual Syndrome Medicine Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Premenstrual Syndrome Medicine by Region, 2022 VS 2029
Figure 54. Premenstrual Syndrome Medicine Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 月経前症候群治療薬の世界市場見通し2023年-2029年(Premenstrual Syndrome Medicine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

月経前症候群治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp